Editorial Board

Editor-in-Chief

Abdul-Rahman Jazieh, MD, MPH
Director of Research and Innovation, Cincinnati Cancer Advisors, Cincinnati, OH , USA

Associate Editor

Khaled Al-Surimi, PhD
University of Doha for Science and Technology, Doha, Qatar

Section Editors

Francisco Rocha-Gonçalves, PhD - Health Economics and Policy Section
Faculty of Medicine, Porto University, Porto, Portugal

Rafael López, MD, PhD - Oncology Section
Head of Service, Medical Oncology Department, Translational Medical Oncology Group, University Clinical Hospital and Health Research Institute (IDIS); CIBERONC; Santiago de Compostela University School of Medicine, Santiago de Compostela, Spain

Assistant Editors

Muhammad Hasan Abid, MD
Fellow, Institute for Healthcare Improvement; Department of Continuous Quality Improvement and Patient Safety, Armed Forces Hospitals, Taif, Saudi Arabia

Augustine Kumah
Quality Directorate, Nyaho Medical Centre, Accra, Ghana

Editorial Board Members

Munir Abu-Helalah, MD, PhD
Global Academy of Health Sciences, Cincinnati, OH, USA; Associate Professor of Epidemiology and Preventive Medicine, Department of Public Health and Community Medicine, Faculty of Medicine, Mutah University, Amman, Jordan

Syed Mohamed Aljunid, MD, MPH, PhD, FAMM, FPHMM, DLSHTM, FASC
National University of Malaysia, Kuala Lumpur, Malaysia

Khaled M. Al-Kattan, MD
Vice President, Administrative and Financial Affairs; Dean, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

William Barrett, MD
Director, University of Cincinnati Cancer Institute; Medical Director, Charles M. Barrett Cancer Center; Professor and Chairman, Radiation Oncology, University of Cincinnati, Cincinnati, OH, USA

Paulo Borem, MD
Senior Director, Institute of Healthcare Improvement, Boston, MA, USA

Ali H. Hajeer, PhD, FRCPath, D(ABHI)
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

Walid Khalbuss, MD, PhD
Deputy Chairman, Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia

JoAnn Lim, PharmD, BCOP
Clinical Pharmacy Specialist, Phase I; Department of Investigational Cancer Therapeutics, Phase I; Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Evangelia D. Razis, MD, PhD
Director, 3rd Department of Medical Oncology, Hygeia Hospital, Athens, Greece

Inês Vaz, Pharm D, PhD
Porto Pharmacovigilance Centre, Faculty of Medicine of University of Porto, Porto, Portugal